Journal of Prevention of Alzheimer's Disease
Published by Elsevier
ISSN : 2274-5807 eISSN : 2426-0266
Abbreviation : J. Prev. Alzheimer's Dis.
Aims & Scope
The JPAD Journal of Prevention of Alzheimer’Diseasewill publish reviews, original research articles and short reports to improve our knowledge in the field of Alzheimer prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and heath economic outcomes.
JPAD will publish also the meeting abstracts from Clinical Trial on Alzheimer Disease (CTAD) and will be distributed both in paper and online version worldwide.
We hope that JPAD with your contribution will play a role in the development of Alzheimer prevention.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 7.8 |
2024 | 8.50 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 3.040 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 41 |
Journal Rank
Year | Value |
---|---|
2024 | 691 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 2244 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
Citation: 692
Authors: Samantha, P.S., F., S., T., S., G., O., K., C., T., C., C.J., K.K., I., L., R., L., Y., C.H., B., S., Y., A.
-
Lecanemab: Appropriate Use Recommendations
Citation: 411
Authors: J., L., G.D., A., P., S., S., D., M., R.C., S.
-
The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention
Citation: 349
Authors: X.-X., Y., Z.-T., Y.-H., Lan, Jin-Tai
-
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021
Citation: 345
Authors: A.P., R.S., Sean, M.N., I.
-
Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research
Citation: 163
Authors: Harald, M.-M., A.C., A.S., A., M.R., P.J., E., Z.S.
-
Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS
Citation: 151
Authors: A., F., T., A., Miia
-
Female Sex and Alzheimer's Risk: The Menopause Connection
Citation: 116
Authors: O., A., H., C., R.S., R., Lisa
-
Early Detection of Mild Cognitive Impairment (MCI) in Primary Care
Citation: 109
Authors: Marwan N., M., S., M., B., J., A., A.P., K.L., G.D., B., S., A., H.
-
Aducanumab: Appropriate Use Recommendations Update
Citation: 104
Authors: Jeffrey, G.D., A., P., L.G., S., M., D., M., S.